EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Aseptic meningitis and acute HIV syndrome after interruption of antiretroviral therapy: implications for structured treatment interruptions



Aseptic meningitis and acute HIV syndrome after interruption of antiretroviral therapy: implications for structured treatment interruptions



Aids 17(14): 2145-2146




(PDF emailed within 0-6 h: $19.90)

Accession: 010204229

Download citation: RISBibTeXText

PMID: 14502028

DOI: 10.1097/01.aids.0000088191.77946.3d



Related references

Aseptic meningitis with elevated adenosine deaminase (ADA) after interruption of antiretroviral treatment. Enfermedades Infecciosas Y Microbiologia Clinica 24(2): 138-139, 2006

Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretroviral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies. Journal of Infectious Diseases 188(10): 1426-1432, 2003

Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions. Journal of Infectious Diseases 197 Suppl 3: S261-S271, 2008

CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials. Antiviral Therapy 15(3): 351-361, 2010

Knowledge of structured treatment interruption and adherence to antiretroviral therapy. Aids Patient Care and Stds 19(3): 167-173, 2005

Ferritin levels during structured treatment interruption of highly active antiretroviral therapy. HIV Medicine 8(6): 388-395, 2007

Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment. Clinical Infectious Diseases 40(5): 728-734, 2005

HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy. Aids 26(11): 1451-1452, 2012

HIV-1 proviral DNA loads (as determined by quantitative PCR) in patients subjected to structured treatment interruption after antiretroviral therapy failure. Journal of Clinical Microbiology 50(6): 2132-2133, 2012

Low Non-structured Antiretroviral Therapy Interruptions in HIV-Infected Persons Who Inject Drugs Receiving Multidisciplinary Comprehensive HIV Care at an Outpatient Drug Abuse Treatment Center. Aids and Behavior 20(5): 1068-1075, 2015

Structured intermittent interruption of chronic HIV infection treatment with highly active antiretroviral therapy: effects on leptin and TNF-alpha. Aids Research and Human Retroviruses 22(4): 307-314, 2006

Reactivation of ancestral strains of HIV-1 in the gp120 V3 env region in patients failing antiretroviral therapy and subjected to structured treatment interruption. Virology 354(1): 35-47, 2006

Structured treatment interruptions in antiretroviral management of HIV-1. Current Opinion in Infectious Diseases 14(1): 29-37, 2002

Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection. Aids 14(15): 2313-2322, 2000

Structured interruptions in antiretroviral treatment: a new therapeutic strategy?. Enfermedades Infecciosas Y Microbiologia Clinica 20(8): 373-375, 2002